Biocon Q3 net up 9% at Rs. 93 cr

Posted By:

Biocon Q3 net up 9% at Rs. 93 cr
Biocon: Quotes, News
BSE 970.55BSE Quote35.3 (3.64%)
NSE 970.65NSE Quote37.5 (3.86%)
Biotechnology major Biocon on Friday posted a 9.38% increase in its consolidated net profit at Rs. 92.81 crore for the third quarter ended December 31, 2012.

The company had posted a net profit of Rs. 84.85 crore during the same period of previous fiscal. Net sales of the company rose to Rs. 634.22 crore for the third quarter, as against Rs. 516.59 crore during the same period of 2011-12 fiscal.

"We have performed well across all our business verticals. We continue to gain market share for biosimilar insulins in ROW (rest of the world) markets which now accounts for a significant part of our business," Biocon chairman and managing director Kiran Mazumdar-Shaw said in a statement.

Shares of Biocon were trading at Rs. 266 on the BSE in the afternoon trade, up 0.89% from its previous close.


Read more about: biocon
Story first published: Friday, January 25, 2013, 12:40 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?